Latest Bayer News & Updates

See the latest news and media coverage for Bayer. We track all announcements, press releases, and industry mentions in real time, all in one place.

Bayer

Life science company in healthcare and agriculture

bayer.com

Headquarters: Leverkusen, Germany
Company type: Public company
Number of employees: 95,000+

Last updated Today

Latest news about Bayer

In short: Bayer reported solid Q1 2026 results driven by its Crop Science division while managing significant legal challenges and pharmaceutical advancements.

Company announcements

Yesterday Bayer

Bayer's Monsanto class settlement case remanded to Missouri State Court

The ruling returns jurisdiction to state court, allowing the approval process to continue and rendering JPML proceedings moot.

Yesterday Bayer

Bayer has completed acquisition of Perfuse Therapeutics

The deal adds a novel treatment for retinal diseases to Bayer's pipeline.

June 15 Bayer

Bayer expands open innovation network in China

The new hub in Shandong focuses on co-developing self-care solutions in skin and digestive health with partners.

June 15 Bayer

Bayer's low-dose MRI contrast agent approved in the US

The agent uses a lower dose of gadolinium while maintaining image quality for MRI scans.

Media coverage

Yesterday Handelsblatt

DAX-listed company: Bayer achieves important success in dispute with glyphosate plaintiffs

The out-of-court settlement of $7.25 billion will now not be examined in Bayer-critical California. This increases the chances for the Leverkusen-based company. The share...

Yesterday WirtschaftsWoche

Glyphosate dispute: Bayer relieved: Judge sends US class action settlement back to state

A US court decision raised hopes among Bayer shareholders for the resolution of lawsuits related to the herbicide Roundup. What's behind it.

Yesterday Goldesel

Bayer shares jump after Supreme Court glyphosate hopes: UBS names

Brief overview: Bayer shares rose significantly on June 17, 2026 and approached a monthly high at midday/opening of the late trading session...

Yesterday wallstreet:online

Bayer's billion-dollar bet: Bayer reaches for the next blockbuster – stock rises | wallstreetONLINE - 17.06.2026

Bayer reaches for a billion-dollar hope for eye diseases. But PER-001 is not yet approved – will the next big coup succeed?

Never miss news about Bayer

Track Bayer and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.